Profile data is unavailable for this security.
About the company
Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
- Revenue in JPY (TTM)44.56bn
- Net income in JPY6.36bn
- Incorporated1965
- Employees1.62k
- LocationFuji Pharma Co Ltd5-7, Samban-cho6F, Seito Kaikan,CHIYODA-KU 102-0075JapanJPN
- Phone+81 335563344
- Fax+81 335564455
- Websitehttps://www.fujipharma.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stella Pharma Corp | 269.49m | -759.81m | 17.83bn | 44.00 | -- | 6.34 | -- | 66.18 | -24.30 | -24.30 | 8.62 | 82.71 | 0.0594 | 0.0517 | 3.98 | 6,124,796.00 | -16.73 | -22.50 | -17.64 | -24.83 | 80.37 | -- | -281.94 | -488.65 | 15.60 | -943.38 | 0.2481 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| Fuso Pharmaceutical Industries Ltd | 56.52bn | 1.53bn | 21.27bn | 1.31k | 12.56 | 0.5159 | 5.64 | 0.3762 | 179.11 | 179.11 | 6,607.60 | 4,361.00 | 0.7454 | 3.08 | 2.35 | 43,245,600.00 | 2.02 | 1.91 | 3.50 | 3.09 | 25.67 | 26.92 | 2.71 | 2.69 | 0.9393 | 36.59 | 0.2767 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| TAIKO PHARMACEUTICAL CO LTD | 6.49bn | -2.33bn | 21.27bn | 208.00 | -- | 2.61 | -- | 3.28 | -46.91 | -46.91 | 130.40 | 160.86 | 0.4474 | 1.91 | 3.71 | 31,211,540.00 | -16.07 | -- | -19.68 | -- | 49.37 | -- | -35.92 | -- | 2.95 | -- | 0.2437 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| Astena Holdings Co Ltd | 53.22bn | 2.10bn | 21.35bn | 1.40k | 9.84 | 0.7258 | 4.91 | 0.4012 | 52.92 | 52.92 | 1,343.58 | 717.87 | 0.8105 | 3.42 | 2.73 | 37,904,980.00 | 3.18 | 2.49 | 5.77 | 4.44 | 33.18 | 25.33 | 3.93 | 2.32 | 0.889 | -- | 0.3439 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.13bn | 27.50bn | 44.00 | -- | 2.93 | -- | -- | -34.87 | -34.87 | 0.00 | 152.36 | 0.00 | -- | -- | 0.00 | -20.52 | -6.71 | -20.87 | -6.83 | -- | -- | -- | -45.80 | 99.90 | -8,295.36 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 30.45bn | 35.00 | -- | 13.89 | -- | 152.64 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Fuji Pharma Co Ltd | 44.56bn | 6.36bn | 33.64bn | 1.62k | 5.19 | 0.7349 | 3.42 | 0.7549 | 261.79 | 261.79 | 1,833.31 | 1,849.15 | 0.5156 | 1.40 | 3.15 | 27,490,440.00 | 7.36 | 4.10 | 11.63 | 5.58 | 39.28 | 42.41 | 14.28 | 7.55 | 0.6276 | -- | 0.3912 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
| Daito Pharmaceutical Co Ltd | 46.90bn | 3.30bn | 36.45bn | 1.01k | 11.30 | 0.6976 | 7.49 | 0.7773 | 210.18 | 210.18 | 2,988.73 | 3,404.72 | 0.6326 | 1.89 | 2.96 | -- | 4.29 | 6.27 | 5.58 | 8.24 | 20.98 | 22.65 | 6.78 | 8.47 | 1.11 | -- | 0.143 | 18.48 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
| Seikagaku Corp | 36.57bn | 2.20bn | 48.24bn | 988.00 | 21.06 | 0.6199 | 12.17 | 1.32 | 40.32 | 40.32 | 670.36 | 1,369.69 | 0.4558 | 2.01 | 4.65 | 37,018,220.00 | 2.74 | 0.4261 | 2.96 | 0.4678 | 47.46 | 54.18 | 6.01 | 0.9814 | 5.04 | -- | 0.0052 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
Data as of Aug 30 2024. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY
9.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Aug 2024 | 548.00k | 2.21% |
| The Vanguard Group, Inc.as of 08 Aug 2024 | 526.12k | 2.13% |
| Dimensional Fund Advisors LPas of 08 Aug 2024 | 340.53k | 1.38% |
| Nikko Asset Management Co., Ltd.as of 09 Aug 2024 | 270.20k | 1.09% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 261.30k | 1.06% |
| Daiwa Asset Management Co. Ltd.as of 31 Jul 2024 | 205.30k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Aug 2024 | 89.10k | 0.36% |
| Mellon Investments Corp.as of 08 Aug 2024 | 69.90k | 0.28% |
| Dimensional Fund Advisors Ltd.as of 08 Aug 2024 | 57.39k | 0.23% |
| Samarang LLPas of 30 Jun 2022 | 55.70k | 0.23% |
More ▼
Data from 30 Jun 2022 - 30 Jun 2024Source: FactSet Research Systems Inc.
